What is the typical cost of Austedo?
The estimated cash price for Austedo, a medication used to treat tardive dyskinesia and chorea associated with Huntington's disease, is approximately $6,495 for a supply of 60 tablets, each at 6mg strength. This price reflects the cost of the drug without insurance [1].
How can I get financial assistance for Austedo?
For those requiring financial assistance, Austedo offers a savings program. The Austedo Savings Card can lower out-of-pocket costs for eligible patients. For commercially insured patients, the savings card may reduce co-pays to as low as $0 per month, with a maximum annual benefit of $5,000. Eligibility and terms apply, and it is not available for patients with government-funded insurance, such as Medicare or Medicaid [2]. Further details on the savings program can be found on the Austedo website.
What is the difference between Austedo and Austedo XR?
Austedo and Austedo XR are both formulations of deutetrabenazine, but they differ in their dosing schedule. Austedo is taken twice daily, while Austedo XR is a once-daily extended-release formulation [3]. This difference in administration may affect patient adherence and convenience.
When does the patent for Austedo expire?
Information regarding the specific patent expiry dates for Austedo can be found on DrugPatentWatch.com. Patent expiration is a critical factor for the potential introduction of generic alternatives and can significantly impact drug pricing in the future [4].
What other treatments are available for tardive dyskinesia?
Besides Austedo, other treatments for tardive dyskinesia include VMAT2 inhibitors like Ingrezza (valbenazine) [5]. The choice of treatment often depends on individual patient needs, physician recommendations, and insurance coverage.